These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15142551)

  • 1. Functionalised 2,3-dimethyl-3-aminotetrahydrofuran-4-one and N-(3-oxo-hexahydrocyclopenta[b]furan-3a-yl)acylamide based scaffolds: synthesis and cysteinyl proteinase inhibition.
    Watts J; Benn A; Flinn N; Monk T; Ramjee M; Ray P; Wang Y; Quibell M
    Bioorg Med Chem; 2004 Jun; 12(11):2903-25. PubMed ID: 15142551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of cis-hexahydropyrrolo[3,2-b]pyrrol-3-one peptidomimetic inhibitors of CAC1 cysteinyl proteinases.
    Quibell M; Benn A; Flinn N; Monk T; Ramjee M; Ray P; Wang Y; Watts J
    Bioorg Med Chem; 2005 Feb; 13(3):609-25. PubMed ID: 15653329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. cis-6-oxo-hexahydro-2-oxa-1,4-diazapentalene and cis-6-oxo-hexahydropyrrolo[3,2-c]pyrazole based scaffolds: design rationale, synthesis and cysteinyl proteinase inhibition.
    Wang Y; Benn A; Flinn N; Monk T; Ramjee M; Watts J; Quibell M
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1327-31. PubMed ID: 15713380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bicyclic peptidomimetic tetrahydrofuro[3,2-b]pyrrol-3-one and hexahydrofuro[3,2-b]pyridine-3-one based scaffolds: synthesis and cysteinyl proteinase inhibition.
    Quibell M; Benn A; Flinn N; Monk T; Ramjee M; Wang Y; Watts J
    Bioorg Med Chem; 2004 Nov; 12(21):5689-710. PubMed ID: 15465346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymmetric synthesis of the cis- and trans-stereoisomers of 4-aminopyrrolidine-3-carboxylic acid and 4-aminotetrahydrofuran-3-carboxylic acid.
    Bunnage ME; Davies SG; Roberts PM; Smith AD; Withey JM
    Org Biomol Chem; 2004 Oct; 2(19):2763-76. PubMed ID: 15455148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total synthesis of epothilones using functionalised allylstannanes for remote stereocontrol.
    Martin N; Thomas EJ
    Org Biomol Chem; 2012 Oct; 10(39):7952-64. PubMed ID: 22940725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formal total synthesis of the potent renin inhibitor aliskiren: application of a SmI2-promoted acyl-like radical coupling.
    Lindsay KB; Skrydstrup T
    J Org Chem; 2006 Jun; 71(13):4766-77. PubMed ID: 16776501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of trimethyl (2S,3R)- and (2R,3R)-[2-2H1]-homocitrates and dimethyl (2S,3R)- and (2R,3R)-[2-2H1]-homocitrate lactones-an assay for the stereochemical outcome of the reaction catalysed both by homocitrate synthase and by the Nif-V protein.
    Tavassoli A; Duffy JE; Young DW
    Org Biomol Chem; 2006 Feb; 4(3):569-80. PubMed ID: 16446817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies towards the enantioselective synthesis of 5,6,8-trisubstituted amphibian indolizidine alkaloids via enaminone intermediates.
    Michael JP; de Koning CB; van der Westhuyzen CW
    Org Biomol Chem; 2005 Mar; 3(5):836-47. PubMed ID: 15731870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of alpha-keto-based inhibitors of cruzain, a cysteine protease implicated in Chagas disease.
    Choe Y; Brinen LS; Price MS; Engel JC; Lange M; Grisostomi C; Weston SG; Pallai PV; Cheng H; Hardy LW; Hartsough DS; McMakin M; Tilton RF; Baldino CM; Craik CS
    Bioorg Med Chem; 2005 Mar; 13(6):2141-56. PubMed ID: 15727867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total synthesis and absolute stereochemistry of pentenocin B, a novel interleukin-1 beta converting enzyme inhibitor.
    Sugahara T; Fukuda H; Iwabuchi Y
    J Org Chem; 2004 Mar; 69(5):1744-7. PubMed ID: 14987040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Total synthesis and properties of prostaglandins. XIV. Amide derivatives of 3alpha-tetrahydrofuranyloxy-5-hydroxyimino-2beta- (3alpha-tetrahydrofuranyloxy-trans-1-octenyl)-cyclopentane- 1alpha-acetic acid].
    Kudriashova VV; Dikovskaia KI; Kalnin'sh AP; Kropivets LS; Freĭmanis IaF
    Bioorg Khim; 1988 Feb; 14(2):216-21. PubMed ID: 3382435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitrile biotransformations for highly enantioselective synthesis of oxiranecarboxamides with tertiary and quaternary stereocenters; efficient chemoenzymatic approaches to enantiopure alpha-methylated serine and isoserine derivatives.
    Wang MX; Deng G; Wang DX; Zheng QY
    J Org Chem; 2005 Apr; 70(7):2439-44. PubMed ID: 15787529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereoselective and efficient synthesis of (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-ol.
    Quaedflieg PJ; Kesteleyn BR; Wigerinck PB; Goyvaerts NM; Vijn RJ; Liebregts CS; Kooistra JH; Cusan C
    Org Lett; 2005 Dec; 7(26):5917-20. PubMed ID: 16354099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-Fmoc-protected(alpha-dipeptidoyl)benzotriazoles for efficient solid-phase peptide synthesis by segment condensation.
    Katritzky AR; Yoshioka M; Narindoshvili T; Chung A; Khashab NM
    Chem Biol Drug Des; 2008 Sep; 72(3):182-8. PubMed ID: 18715231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of a diverse library of mechanism-based cysteine protease inhibitors.
    Wood WJ; Huang L; Ellman JA
    J Comb Chem; 2003; 5(6):869-80. PubMed ID: 14606817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Synthesis of d,1-4 beta-(3'-oxo-trans-octen-(1'))-5 alpha-benzoyloxy-3,3a beta,4,5,6,6a beta-hexahydro-2H-cyclopenta(b)furan-2-one(Ib)].
    Wu YL; Hu JY; Yang GZ; Jin BY; Wang ZR
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1983 Oct; 5(5):315-8. PubMed ID: 6234082
    [No Abstract]   [Full Text] [Related]  

  • 18. Solid-phase synthesis of azidomethylene inhibitors targeting cysteine proteases.
    Yang PY; Wu H; Lee MY; Xu A; Srinivasan R; Yao SQ
    Org Lett; 2008 May; 10(10):1881-4. PubMed ID: 18407644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of small molecule human C5a receptor antagonists.
    Sanganee HJ; Baxter A; Barber S; Brown AJ; Grice D; Hunt F; King S; Laughton D; Pairaudeau G; Thong B; Weaver R; Unitt J
    Bioorg Med Chem Lett; 2009 Feb; 19(4):1143-7. PubMed ID: 19171482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient asymmetric synthesis of novel 4-substituted and configurationally stable analogues of thalidomide.
    Yamada T; Okada T; Sakaguchi K; Ohfune Y; Ueki H; Soloshonok VA
    Org Lett; 2006 Nov; 8(24):5625-8. PubMed ID: 17107088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.